Emvision Medical Devices Ltd (EMV)

EMV Chart

vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Advanced

Show News Mov Avgs 9-day 10-day 20-day 30-day 50-day 100-day 150-day 200-day Mov Avgs 9-day 21-day 30-day 200-day Simple Exponential Weighted Simple Exponential Weighted vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Mov Avgs 10-day 20-day 30-day 50-day 100-day 150-day 200-day 9/21 Cross 10/30 Cross Golden Cross Vol RSI BB

Day 3m 6m 1yr 5yr 10yr

EMV's Principal Activity is the research and development of medical imaging and diagnostic technology previously licensed and subsequently acquired from Uniquest Pty Limited (Uniquest) (the EMVision Technology), for the purpose of commercialising a portable medical device for stroke diagnosis and monitoring as well as other medical imaging needs.

Announcements

Company Overview

Dividend History

Directors & Management

Name	Title	Since	Bio
Dr Phillip James Dubois	Non-Executive Director	Sep 2020	Dr Phillip James Dubois Non-Executive Director Dr Dubois is Non-executive Director of Sonic Healthcare (ASX:SHL), former CEO of their imaging division and served as Executive Director from 2001 to 2020. He is also the founder and former CEO and Chairman of Queensland X-Ray. Dr Dubois is currently an Associate Professor of Radiology at the University of Queensland Medical School. He has served on numerous government and radiology group bodies, including the councils of the Royal Australian and New Zealand College of Radiologists and the Australian Medical Association, and as Vice-President of the Australian Diagnostic Imaging Association. Dr Dubois is a Non-executive Director of Magnetica Limited.
Dr Ronald (Ron) Peter Weinberger	Chief Executive Officer,Managing Director	May 2020	Dr Ronald (Ron) Peter Weinberger Chief Executive Officer,Managing Director Dr Weinberger has more than 20 years' experience in medical research, biotechnology and commercialization. Dr Weinberger joined Nanosonics in August 2004 and was appointed as Executive Director in July 2008 then Managing Director and Chief Executive Officer December 2011 with a period as acting CEO from May 2011. From October 2013 to February 2018, Dr Weinberger was responsible for the direction of Nanosonics' technology development and commercialisation strategy. He is co-inventor of several of Nanosonics' technology patents.
Mr Anthony (Tony) Keane	Non-Executive Director	Jun 2018	Mr Anthony (Tony) Keane Non-Executive Director Mr Keane is an experienced business and finance executive and holds a number of independent non-executive director and advisory board roles. Mr Keane also undertakes finance advisory and consultancy assignments for various business clients and previously held roles with trading bank principally in business, corporate and institutional banking. Mr Keane is currently an Independent Non-Executive Director of National Storage Holdings Ltd, the holding company established for National Storage REIT, and director of Queensland Symphony Orchestra Holdings Ltd. He is Chair of Risk Committee.
Mr John Keep	Non-Executive Chairman,Non-Executive Director	Mar 2018	Mr John Keep Non-Executive Chairman,Non-Executive Director Mr Keep has public company board experience as well as senior management experience in the healthcare and hospitality sectors including managing start up enterprises and medical diagnostic companies. Mr Keep led the restructuring and revitalization of the radiology company Queensland Diagnostic Imaging and at Lemarne Healthcare. Mr Keep is a director of Queensland Symphony Orchestra Holdings Ltd and a member of that company's Finance Audit and Risk Committee. He is Member of Risk Committee.
Mr Geoffrey (Geoff) Richard Pocock	Non-Executive Director	Mar 2018	Mr Geoffrey (Geoff) Richard Pocock Non-Executive Director Mr Pocock has experience as a corporate advisor and strategy consultant advising companies on commercialisation and IP management, business development, mergers and acquisitions strategy and raising equity capital from private and public equity markets. Mr Pocock is currently the principal of Polaris Consulting (WA) Pty Ltd. He is Member of Risk Committee.
Mr Scott Kirkland	Co-founder,Executive Director	Jul 2017	Mr Scott Kirkland Co-founder,Executive Director Mr Kirkland has held several senior sales positions, including Head of Client Sales at Quantcast. Mr Kirkland is a co-founder of the Company and oversees its corporate affairs, commercial strategy and business development efforts.
Ms Emma Waldon	Chief Financial Officer,Company Secretary	N/A

Show All

Director Transactions

Date	Director	Type	Amount	Price	Value	Notes
14/04/21	Ronald (Ron) Weinberger	Buy	+17,200	$2.88	$49,534	On-market trade
07/12/20	Phillip Dubois	Issued	500,000	$3.34	$1,670,000	Issue of options
07/12/20	Ronald (Ron) Weinberger	Issued	1,000,000	$3.34	$3,340,000	Issue of options
01/12/20	Geoffrey (Geoff) Pocock	Buy	+5,000	$3.30	$16,500	On-market trade
01/10/20	Phillip Dubois	Buy	+40,000	$2.50	$100,000	Off-market trade
04/06/19	Ryan Laws	Buy	+14,844	$0.38	$5,641	On-market trade
03/06/19	Ryan Laws	Buy	+15,156	$0.368	$5,582	On-market trade
21/12/18	Scott Kirkland	Buy	+17,766	$0.304	$5,401	On-market trade
20/12/18	Scott Kirkland	Buy	+35,634	$0.303	$10,797	On-market trade
19/12/18	Geoffrey (Geoff) Pocock	Buy	+50,000	$0.301	$15,041	On-market trade

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Ronald (Ron) Weinberger	14/04/2021	1,017,200	20,000	2,000,000	N/A
Phillip Dubois	07/12/2020	N/A	47,500	500,000	N/A
Geoffrey (Geoff) Pocock	01/12/2020	N/A	355,000	500,000	N/A
Scott Kirkland	30/06/2020	3,333,400	415,000	600,000	N/A
John Keep	30/06/2020	N/A	1,707,500	400,000	N/A
Anthony (Tony) Keane	30/06/2020	100,000	N/A	500,000	N/A

Show All

Top 20 Shareholders About the Data

Name	Shares	Capital
Uniquest Pty Ltd	6,000,000	8.55%
Mr Scott Philip Kirkland	3,333,400	4.75%
Ryan Michael Laws	3,212,500	4.58%
Glensburg Pty Ltd	1,100,000	1.57%
Walsh Prestige Pty Ltd	1,040,000	1.48%
Mr Bryant James Mclarty	1,023,688	1.46%
Mr Martin Kolev	1,000,000	1.42%
Ronald Weinberger	1,000,000	1.42%
Dr Stuart Crozier	1,000,000	1.42%
Kong Pak Lim	939,500	1.34%
Hillridge Pty Ltd	900,000	1.28%
Wakil Family Group Pty Ltd	840,437	1.20%
Mr Paul Raymond Brown & Mrs Angelique Susan Brown	827,277	1.18%
Bellcoo Investments Pty Ltd	770,000	1.10%
Neweconomy Com Au Nominees Pty Limited	758,288	1.08%
Macequest Pty Limited	741,298	1.06%
Jm Starcevich Investments Pty Ltd	696,660	0.99%
Ross D Smith Investments Pty Ltd	696,084	0.99%
Forza Management Pty Ltd	672,500	0.96%
Shah Nominees Pty Ltd	625,000	0.89%
John Keep & Sons Pty Ltd	607,500	0.86%
Mrs Carol Anne Kirkland	539,350	0.77%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
2020	$1.34	30 June
2019	$0.365	28 June

EMV Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.